Ogasawara, Ken http://orcid.org/0000-0002-4264-8927
Kam, Jeanelle
Thomas, Mark
Liu, Liangang
Liu, Mary
Xue, Yongjun
Surapaneni, Sekhar
Carayannopoulos, Leonidas N.
Zhou, Simon
Palmisano, Maria
Krishna, Gopal
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participants
https://doi.org/10.1007/s00280-021-04292-4
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 5 February 2021
Accepted: 3 May 2021
First Online: 21 May 2021
Declarations
:
: KO, MT, LL, ML, YX, SS, LNC, SZ, MP, and GK are employees of and hold equity ownership in Bristol Myers Squibb. JK is an employee of Covance.
: All study procedures were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments.
: Informed consent to participate was obtained from all individual participants included in the study.
: The authors consented to submit the manuscript for publication.